Cargando…
Biosimilar Uptake: The Importance of Healthcare Provider Education
From peptide hormones to monoclonal antibodies, advances in biotherapeutic medicines, or biologics, have brought incalculable benefits to patients, especially for conditions where previous classes of therapy were ineffective or non-existent. At the same time, the development of biologics has been ac...
Autores principales: | Oskouei, Sonia Tadjalli, Kusmierczyk, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421278/ https://www.ncbi.nlm.nih.gov/pubmed/34420201 http://dx.doi.org/10.1007/s40290-021-00396-7 |
Ejemplares similares
-
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
por: Kim, HoUng, et al.
Publicado: (2020) -
Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study
por: Hanzel, Jurij, et al.
Publicado: (2021) -
Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability
por: Cozijnsen, M. A., et al.
Publicado: (2017) -
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics
por: Shah, Rashmi R.
Publicado: (2017) -
FACTORS INFLUENCING PATIENTS’ UTILIZATION OF PRIMARY HEALTH CARE PROVIDERS IN SAUDI ARABIA
por: Al-Omar, Badran A., et al.
Publicado: (1998)